贝瑞基因
(000710)
| 流通市值：32.95亿 | | | 总市值：34.72亿 |
| 流通股本：3.36亿 | | | 总股本：3.54亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 676,598,645.04 | 446,766,809.76 | 210,215,582.68 | 929,818,022.06 |
| 营业总成本 | 717,441,912.89 | 462,287,478.74 | 217,562,649.71 | 1,009,161,258.53 |
| 其他经营收益 | | | | |
| 营业利润 | -86,866,472.73 | -36,715,065.58 | -17,697,150.76 | -187,335,591.04 |
| 利润总额 | -92,068,309.22 | -36,176,584.02 | -17,582,816.16 | -189,556,166.06 |
| 净利润 | -100,821,917.27 | -43,116,696.55 | -19,069,431.37 | -196,294,138.02 |
| 每股收益 | | | | |
| 其他综合收益 | -26,726,554.25 | -7,132,745.91 | -4,233,147.77 | -5,649,446.76 |
| 综合收益总额 | -127,548,471.52 | -50,249,442.46 | -23,302,579.14 | -201,943,584.78 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,091,210,770.19 | 1,131,625,743.33 | 1,176,987,465.17 | 1,244,082,293.78 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,026,442,619.59 | 1,030,383,991.1 | 1,038,776,447.44 | 1,040,154,653.33 |
| 资产总计 | 2,117,653,389.78 | 2,162,009,734.43 | 2,215,763,912.61 | 2,284,236,947.11 |
| 流动负债: | | | | |
| 流动负债合计 | 570,616,029.86 | 533,267,195.78 | 559,547,889.76 | 635,994,474.78 |
| 非流动负债: | | | | |
| 非流动负债合计 | 174,815,055.3 | 174,899,331.56 | 145,425,952.44 | 144,149,822.78 |
| 负债合计 | 745,431,085.16 | 708,166,527.34 | 704,973,842.2 | 780,144,297.56 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,359,259,931.4 | 1,422,147,722.61 | 1,453,026,421.88 | 1,476,245,609.06 |
| 股东权益合计 | 1,372,222,304.62 | 1,453,843,207.09 | 1,510,790,070.41 | 1,504,092,649.55 |
| 负债和股东权益合计 | 2,117,653,389.78 | 2,162,009,734.43 | 2,215,763,912.61 | 2,284,236,947.11 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 688,362,212.45 | 443,730,903.67 | 206,722,702.38 | 1,095,475,926.23 |
| 经营活动现金流出小计 | 821,838,266.72 | 545,990,089.02 | 298,355,151.97 | 1,024,868,193.54 |
| 经营活动产生的现金流量净额 | -133,476,054.27 | -102,259,185.35 | -91,632,449.59 | 70,607,732.69 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 6,170,229.85 | 6,126,047.85 | 6,108,047.85 | 22,001,548.38 |
| 投资活动现金流出小计 | 42,477,786.48 | 31,943,775.89 | 19,749,812.17 | 87,746,350.17 |
| 投资活动产生的现金流量净额 | -36,307,556.63 | -25,817,728.04 | -13,641,764.32 | -65,744,801.79 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 313,048,868.9 | 155,048,868.9 | 145,048,868.9 | 184,448,975.65 |
| 筹资活动现金流出小计 | 322,817,897.19 | 172,647,346.38 | 115,468,486.12 | 172,392,535.09 |
| 筹资活动产生的现金流量净额 | -9,769,028.29 | -17,598,477.48 | 29,580,382.78 | 12,056,440.56 |
| 汇率变动对现金及现金等价物的影响 | -5,287,526.38 | -3,349,260.9 | -2,225,966.99 | -3,027,599.87 |
| 现金及现金等价物净增加额 | -184,840,165.57 | -149,024,651.77 | -77,919,798.12 | 13,891,771.59 |
| 期末现金及现金等价物余额 | 187,364,420.16 | 223,179,933.96 | 294,284,787.61 | 372,204,585.73 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -149,024,651.77 | - | 13,891,771.59 |